Previous articles reported that the hepatic CEACAM1 expression was markedly decreased in the severely obese subjects, high grade fatty livers and NASH, but not different between diabetic and non-diabetic persons [20]. The gene discussed is CEACAM1; the disease is metabolic dysfunction-associated steatohepatitis.